<DOC>
	<DOCNO>NCT00092833</DOCNO>
	<brief_summary>The purpose study provide investigational drug patient specific type hypercholesterolemia ( high cholesterol ) sitosterolemia ( unusually high absorption non-cholesterol sterol ) treatment use setting .</brief_summary>
	<brief_title>Investigational Drug Patients With Hypercholesterolemia Patients With Sitosterolemia ( 0653-026 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Lipid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Hyperlipoproteinemia Type II</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Homozygous familial hypercholesterolemia sitosterolemia Patient condition , opinion investigator , might pose risk patient , interfere participation study , meet additional criterion require study</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>